SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-005803
Filing Date
2020-05-08
Accepted
2020-05-07 17:54:30
Documents
56
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q xncr-20200507x10q.htm   iXBRL 10-Q 1416911
2 EX-31.1 xncr-20200331xex31d1.htm EX-31.1 19396
3 EX-31.2 xncr-20200331xex31d2.htm EX-31.2 19380
4 EX-32.1 xncr-20200331xex32d1.htm EX-32.1 10571
  Complete submission text file 0001558370-20-005803.txt   6436633

Data Files

Seq Description Document Type Size
5 EX-101.SCH xncr-20200507.xsd EX-101.SCH 38267
6 EX-101.CAL xncr-20200507_cal.xml EX-101.CAL 49571
7 EX-101.DEF xncr-20200507_def.xml EX-101.DEF 159492
8 EX-101.LAB xncr-20200507_lab.xml EX-101.LAB 432087
9 EX-101.PRE xncr-20200507_pre.xml EX-101.PRE 311532
35 EXTRACTED XBRL INSTANCE DOCUMENT xncr-20200507x10q_htm.xml XML 1247275
Mailing Address 111 WEST LEMON AVE MONROVIA CA 91016
Business Address 111 WEST LEMON AVE MONROVIA CA 91016 626-305-5900
Xencor Inc (Filer) CIK: 0001326732 (see all company filings)

IRS No.: 201622502 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36182 | Film No.: 20857946
SIC: 2834 Pharmaceutical Preparations